ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 120,80
-0,94%
Dow Jones
42 801,72
0,52%
DAX
23 008,94
-1,87%
Brent Oil
70,235
0,00%
Bitcoin
82 550,99
-4,17%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ

  6. Taysha Gene Therapies Inc (TSHA) Cours

Taysha Gene Therapies Inc

Taysha Gene Therapies Inc (TSHA)

NASDAQ
1,75
0,06
(3,55%)
Fermé 09 Mars 9:00PM
Retardé de 15 minutes
1,755
0,005
(0,29%)
Après les heures de négociation: 1:59AM
Retardé de 15 minutes

Outils de qualité professionnelle, pour des investisseurs individuels.

Premium

Statistiques et détails clés

Dernier
1,75
Prix Achat
1,39
Prix Vente
3,98
Volume échangé
1 136 032
1,66 Fourchette du Jour 1,765
1,19 Plage de 52 semaines 4,32
Cap du marché
358,753M
Clôture Veille
1,69
Ouverture
1,68
Dernière Transaction
1
@
1.75
Dernière heure de transaction
Volume financier
US$ 1 967 211
VWAP
1,7317
Volume moyen (3 m)
2 185 322
Actions en circulation
205 001 632
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-3,22
Bénéfice par action (BPA)
-0,54
Chiffre d'affairess
15,45M
Bénéfice net
-111,57M

À propos de Taysha Gene Therapies Inc

Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and com... Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. It is advancing a deep and sustainable product portfolio of 18 gene therapy product candidates, with exclusive options to acquire four additional development programs. Its product candidates include TSHA-101, TSHA-118, TSHA-102, TSHA-103, and TSHA-104. Show more

Secteur
Biological Pds,ex Diagnstics
Industrie
Biological Pds,ex Diagnstics
Site Web
www.tayshagtx.com
Siège social
Dover, Delaware, USA
Fondé
-
Taysha Gene Therapies Inc est coté dans le secteur Biological Pds,ex Diagnstics de la NASDAQ avec le ticker TSHA. Le dernier cours de clôture d'Taysha Gene Therapies était de US$1,69. Au cours de la dernière année, les actions de Taysha Gene Therapies ont été négociées dans une fourchette de prix de US$ 1,19 à US$ 4,32.

Taysha Gene Therapies compte actuellement 205 001 632 actions en circulation. La capitalisation boursière d'Taysha Gene Therapies est de US$346,45 million. Taysha Gene Therapies a un ratio cours/bénéfice (ratio PE) de -3.22.

TSHA Dernières nouvelles

Plus de nouvelles

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Edgar (US Regulatory)
26 Février 2025
TSHA (3,55%)

Form 8-K - Current report
Edgar (US Regulatory)
26 Février 2025
TSHA (3,55%)

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Edgar (US Regulatory)
06 Février 2025
TSHA (3,55%)

Form S-8 - Securities to be offered to employees in employee benefit plans
Edgar (US Regulatory)
07 Janvier 2025
TSHA (3,55%)

Form EFFECT - Notice of Effectiveness
Edgar (US Regulatory)
23 Décembre 2024
TSHA (3,55%)
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10.1610.06289308181.591.81.5716463021.64513554CS
40.052.941176470591.71.8851.4619062501.65998226CS
12-0.5-22.22222222222.252.2651.43521853221.72124099CS
26-0.31-15.04854368932.063.311.1932656762.0358804CS
52-1.005-36.47912885662.7554.321.1927284372.33204319CS
156-3.91-69.08127208485.667.07740.519603042.30568687CS
260-20.5-92.134831460722.2533.840.513722072.90973686CS

TSHA - Frequently Asked Questions (FAQ)

What is the current Taysha Gene Therapies share price?
The current share price of Taysha Gene Therapies is US$ 1,75
How many Taysha Gene Therapies shares are in issue?
Taysha Gene Therapies has 205 001 632 shares in issue
What is the market cap of Taysha Gene Therapies?
The market capitalisation of Taysha Gene Therapies is USD 346,45M
What is the 1 year trading range for Taysha Gene Therapies share price?
Taysha Gene Therapies has traded in the range of US$ 1,19 to US$ 4,32 during the past year
What is the PE ratio of Taysha Gene Therapies?
The price to earnings ratio of Taysha Gene Therapies is -3,22
What is the cash to sales ratio of Taysha Gene Therapies?
The cash to sales ratio of Taysha Gene Therapies is 23,21
What is the reporting currency for Taysha Gene Therapies?
Taysha Gene Therapies reports financial results in USD
What is the latest annual turnover for Taysha Gene Therapies?
The latest annual turnover of Taysha Gene Therapies is USD 15,45M
What is the latest annual profit for Taysha Gene Therapies?
The latest annual profit of Taysha Gene Therapies is USD -111,57M
What is the registered address of Taysha Gene Therapies?
The registered address for Taysha Gene Therapies is 108 LAKELAND AVE, DOVER, DELAWARE, 19901
What is the Taysha Gene Therapies website address?
The website address for Taysha Gene Therapies is www.tayshagtx.com
Which industry sector does Taysha Gene Therapies operate in?
Taysha Gene Therapies operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
ABLVAble View Global Inc
US$ 1,73
(137,18%)
5,14M
SUNESUNation Energy Inc
US$ 0,402999
(127,55%)
482,05M
BTOGBit Origin Ltd
US$ 0,6117
(118,46%)
622,67M
DWTXDogwood Therapeutics Inc
US$ 6,63
(49,66%)
25,92M
KZIAKazia Therapeutics Ltd
US$ 1,1899
(40,80%)
4,5M
ALBTAvalon GloboCare Corporation
US$ 6,96
(-36,15%)
577,55k
SCNXScienture Holdings Inc
US$ 1,55
(-35,68%)
1,59M
ACXPAcurx Pharmaceuticals Inc
US$ 0,4572
(-29,88%)
1,18M
RETOReTo Eco Solutions Inc
US$ 5,42
(-27,73%)
108,27k
OCTOEightco Holdings Inc
US$ 1,08
(-27,03%)
336,99k
BTOGBit Origin Ltd
US$ 0,6117
(118,46%)
618,03M
SUNESUNation Energy Inc
US$ 0,402999
(127,55%)
476,73M
NVDANVIDIA Corporation
US$ 112,69
(1,92%)
333,91M
ICONIcon Energy Corporation
US$ 0,169898
(17,17%)
140,23M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 10,675
(-0,70%)
140,05M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

NASDAQ
TSHA
Taysha Gene Therapies
BITMOT
881448
Rekeep Tf 7,25% Fb26 Cal...
TG
TLXD
Talanx
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés

Supprimer les publicités

Inscrivez-vous pour une expérience sans publicité

Aucune publicité

Essayez maintenant

Conserver les annonces